These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

492 related items for PubMed ID: 9095257

  • 1. Allergen dose dependent cytokine production regulates specific IgE and IgG antibody production.
    Blaser K.
    Adv Exp Med Biol; 1996; 409():295-303. PubMed ID: 9095257
    [Abstract] [Full Text] [Related]

  • 2. Determinants and mechanisms of human immune responses to bee venom phospholipase A2.
    Blaser K, Carballido J, Faith A, Crameri R, Akdis C.
    Int Arch Allergy Immunol; 1998 Sep; 117(1):1-10. PubMed ID: 9751842
    [Abstract] [Full Text] [Related]

  • 3. Differential regulation of human T cell cytokine patterns and IgE and IgG4 responses by conformational antigen variants.
    Akdis CA, Blesken T, Wymann D, Akdis M, Blaser K.
    Eur J Immunol; 1998 Mar; 28(3):914-25. PubMed ID: 9541587
    [Abstract] [Full Text] [Related]

  • 4. Regulation of IgE and IgG4 responses by allergen specific T-cell clones to bee venom phospholipase A2 in vitro.
    Carballido JM, Carballido-Perrig N, Oberli-Schrämmli A, Heusser CH, Blaser K.
    J Allergy Clin Immunol; 1994 Apr; 93(4):758-67. PubMed ID: 8163785
    [Abstract] [Full Text] [Related]

  • 5. Glucocorticoids inhibit human antigen-specific and enhance total IgE and IgG4 production due to differential effects on T and B cells in vitro.
    Akdis CA, Blesken T, Akdis M, Alkan SS, Heusser CH, Blaser K.
    Eur J Immunol; 1997 Sep; 27(9):2351-7. PubMed ID: 9341780
    [Abstract] [Full Text] [Related]

  • 6. Induction and differential regulation of bee venom phospholipase A2-specific human IgE and IgG4 antibodies in vitro requires allergen-specific and nonspecific activation of T and B cells.
    Akdis CA, Blesken T, Akdis M, Alkan SS, Wüthrich B, Heusser CH, Blaser K.
    J Allergy Clin Immunol; 1997 Mar; 99(3):345-53. PubMed ID: 9058690
    [Abstract] [Full Text] [Related]

  • 7. Enzymatic activity of soluble phospholipase A2 does not affect the specific IgE, IgG4 and cytokine responses in bee sting allergy.
    Wymann D, Akdis CA, Blesken T, Akdis M, Crameri R, Blaser K.
    Clin Exp Allergy; 1998 Jul; 28(7):839-49. PubMed ID: 9720818
    [Abstract] [Full Text] [Related]

  • 8. Epitope-specific T cell tolerance to phospholipase A2 in bee venom immunotherapy and recovery by IL-2 and IL-15 in vitro.
    Akdis CA, Akdis M, Blesken T, Wymann D, Alkan SS, Müller U, Blaser K.
    J Clin Invest; 1996 Oct 01; 98(7):1676-83. PubMed ID: 8833918
    [Abstract] [Full Text] [Related]

  • 9. Successful immunotherapy with T-cell epitope peptides of bee venom phospholipase A2 induces specific T-cell anergy in patients allergic to bee venom.
    Müller U, Akdis CA, Fricker M, Akdis M, Blesken T, Bettens F, Blaser K.
    J Allergy Clin Immunol; 1998 Jun 01; 101(6 Pt 1):747-54. PubMed ID: 9648701
    [Abstract] [Full Text] [Related]

  • 10. Bee venom phospholipase A2-specific T cell clones from human allergic and non-allergic individuals: cytokine patterns change in response to the antigen concentration.
    Carballido JM, Carballido-Perrig N, Terres G, Heusser CH, Blaser K.
    Eur J Immunol; 1992 Jun 01; 22(6):1357-63. PubMed ID: 1601030
    [Abstract] [Full Text] [Related]

  • 11. T cell epitope specificity in human allergic and nonallergic subjects to bee venom phospholipase A2.
    Carballido JM, Carballido-Perrig N, Kägi MK, Meloen RH, Wüthrich B, Heusser CH, Blaser K.
    J Immunol; 1993 Apr 15; 150(8 Pt 1):3582-91. PubMed ID: 7682244
    [Abstract] [Full Text] [Related]

  • 12. Carbohydrate-dependent, HLA class II-restricted, human T cell response to the bee venom allergen phospholipase A2 in allergic patients.
    Dudler T, Altmann F, Carballido JM, Blaser K.
    Eur J Immunol; 1995 Feb 15; 25(2):538-42. PubMed ID: 7875217
    [Abstract] [Full Text] [Related]

  • 13. Role of interleukin 10 in specific immunotherapy.
    Akdis CA, Blesken T, Akdis M, Wüthrich B, Blaser K.
    J Clin Invest; 1998 Jul 01; 102(1):98-106. PubMed ID: 9649562
    [Abstract] [Full Text] [Related]

  • 14. Prevention of allergy by a recombinant multi-allergen vaccine with reduced IgE binding and preserved T cell epitopes.
    Karamloo F, Schmid-Grendelmeier P, Kussebi F, Akdis M, Salagianni M, von Beust BR, Reimers A, Zumkehr J, Soldatova L, Housley-Markovic Z, Müller U, Kündig T, Kemeny DM, Spangfort MD, Blaser K, Akdis CA.
    Eur J Immunol; 2005 Nov 01; 35(11):3268-76. PubMed ID: 16206231
    [Abstract] [Full Text] [Related]

  • 15. High-dose bee venom exposure induces similar tolerogenic B-cell responses in allergic patients and healthy beekeepers.
    Boonpiyathad T, Meyer N, Moniuszko M, Sokolowska M, Eljaszewicz A, Wirz OF, Tomasiak-Lozowska MM, Bodzenta-Lukaszyk A, Ruxrungtham K, van de Veen W.
    Allergy; 2017 Mar 01; 72(3):407-415. PubMed ID: 27341567
    [Abstract] [Full Text] [Related]

  • 16. Bee venom immunotherapy results in decrease of IL-4 and IL-5 and increase of IFN-gamma secretion in specific allergen-stimulated T cell cultures.
    Jutel M, Pichler WJ, Skrbic D, Urwyler A, Dahinden C, Müller UR.
    J Immunol; 1995 Apr 15; 154(8):4187-94. PubMed ID: 7706753
    [Abstract] [Full Text] [Related]

  • 17. Antagonistic peptides specifically inhibit proliferation, cytokine production, CD40L expression, and help for IgE synthesis by Der p 1-specific human T-cell clones.
    Fasler S, Aversa G, de Vries JE, Yssel H.
    J Allergy Clin Immunol; 1998 Apr 15; 101(4 Pt 1):521-30. PubMed ID: 9564806
    [Abstract] [Full Text] [Related]

  • 18. Nonallergic individuals recognize the same T cell epitopes of Bet v 1, the major birch pollen allergen, as atopic patients.
    Ebner C, Schenk S, Najafian N, Siemann U, Steiner R, Fischer GW, Hoffmann K, Szépfalusi Z, Scheiner O, Kraft D.
    J Immunol; 1995 Feb 15; 154(4):1932-40. PubMed ID: 7530747
    [Abstract] [Full Text] [Related]

  • 19. Allergen-specific T-cell tolerance induction with allergen-derived long synthetic peptides: results of a phase I trial.
    Fellrath JM, Kettner A, Dufour N, Frigerio C, Schneeberger D, Leimgruber A, Corradin G, Spertini F.
    J Allergy Clin Immunol; 2003 Apr 15; 111(4):854-61. PubMed ID: 12704369
    [Abstract] [Full Text] [Related]

  • 20. IL-10-induced anergy in peripheral T cell and reactivation by microenvironmental cytokines: two key steps in specific immunotherapy.
    Akdis CA, Blaser K.
    FASEB J; 1999 Apr 15; 13(6):603-9. PubMed ID: 10094921
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 25.